SEOUL, South Korea, Jan. 18, 2022 /PRNewswire/ Lunit today announced a Reference Site Agreement with Baheya Foundation for Early Detection & Treatment of Breast Cancer, a non-profit organization
right now. in fact, they re all having a hard time recruiting. o donnell: all right. thank you, jeff. now an update in our investigation in partnership with clear health costs into what women are paying for mammograms and other medical tests. we heard from hundreds of you, including breast cancer survivors, who want to know why follow-up tests are sometimes not covered by insurance. it s another case of medical price roulette and anna werner investigates. kristen hoffman fought breast cancer a year ago. now she s battling to get her insurance company cigna to pay for her mammograms. you just feel like you re getting the run around. and sometimes you don t have the bandwidth to fight the battle. reporter: the affordable care act requires insurance companies to pay for regular screening mammograms for women 40 and over, but many breast cancer survivors need diagnostic mammograms, similar tests read more quickly, and insurance companies often won t pay for them. i was gobsmacked
sicker individuals in the risk pools particularly in smaller states. we need to adequately fund high-risk pools that doesn t necessarily mean cost-sharing for young and healthy individual who is are having to pay for older individual who is have chronic illnesses and many are self-inflicted. we need positive incentives for preventive medicine and healthy behaviors. i had a patient recently who came in, she had a mass, breast cancer, overweight, i didn t get my screening mammograms because i don t like the feeling of compression of a mem mammogram and she has no desire to quitting because she likes soda. eric: ten seconds, doctor, do you think whether he get some place with the health care bill, finally? i really don t know, i think the only way to get senator
your family history of cancer. breast cancer, you e need to look at whether or not there s any genetic mutations that are known in your family, whether you have a history such as being jewish heritage that would affect your risk. it s not a simple discussion. it s something that s much more nuanced than saying 40 or 45 or 50. you look like you want to jump in. i would love to. that s exactly what we said in the report. that s exactly what the american cancer society embraces. we want the decisions to be informed decisions. assess on a variety of different factors. when it becomes very clear for women that are at average risk that don t have a family history for screening mammograms, but there are tradeoffs. we want women to understand those trade yufs. both the women in our country are savvy about this and health care providers have the opportunity to share this